UK-listed but US-focused healthcare software provider Craneware is benefiting from the cost pressures on American hospitals.
The company, which provides monitoring and automated revenue systems, has reported revenues of $41.1m in the 12 months to the end of June, a rise of 8% on the prior year.
Adjusted profits before tax came in at $10.8m, a 16% gain on the previous year, while the total dividend for the year has been announced at 10.5p per share, versus 8.8p in 2011.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Craneware's Chief Executive, Keith Neilson, said of the results: "Added pressures on US hospitals have led to an increased sales and opportunity pipeline for our products as we move into the current financial year.
"In this turbulent, demanding environment, hospitals need financial accuracy, visibility and shared accountability to survive. Fiscal and regulatory drivers are expected to increase in the year ahead as they push for greater transparency and accuracy, and although this creates a challenging ever-evolving marketplace, it ultimately increases the opportunities for Craneware's solutions."
The market was impressed with the numbers: the stock was up 7.6% at 10:08.
BS
-
Shein shifts IPO focus to Hong KongThe development piles fresh pressure on London’s beleaguered stock market, which many had hoped would be boosted by Shein’s IPO
-
Scientists turn lead into gold – could it wreck the yellow metal's price?Medieval alchemists have been vindicated after scientists turned lead into gold, but the results aren’t going to crash the gold price any time soon
